BiotechTube
Tetrad Discovery

Tetrad Discovery

Cambridge, United Kingdom· Est.
t4bio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Tetrad Discovery is a privately-held, revenue-generating Contract Research Organisation (CRO) located in Kent, United Kingdom. Founded by ex-Pfizer scientists, the company offers integrated, client-tailored bio-analysis and pharmacology services to support drug discovery, primarily in areas like urology, respiratory, cardiovascular, and safety pharmacology. Its business model is purely service-based, differentiating itself through personalized work packages, hands-on collaboration, and expertise in complex physiological models. The company appears to be a small, founder-led operation with an estimated employee count in the single digits.

UrologyRespiratoryCardiovascularSafety PharmacologyPainRenal

Technology Platform

Integrated suite of in vivo and in vitro pharmacological expertise, including custom in vivo disease models, tissue bath studies, histological procedures, and a specialized ELLA automated immunoassay platform for bespoke bio-analysis.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

Growth in biopharma outsourcing, especially from virtual and small biotechs needing specialized in vivo expertise without building internal capacity.
The company's bespoke, partnership-focused model addresses a gap left by larger, less flexible CROs.
Strategic location in the UK life sciences hub provides access to a dense network of potential clients.

Risk Factors

High dependence on a small number of clients and key personnel creates vulnerability.
Intense competition from both large global CROs and other boutique providers pressures pricing and client acquisition.
Revenue is subject to volatility based on project cycles and broader economic conditions affecting biopharma R&D budgets.

Competitive Landscape

Tetrad operates in the highly competitive global CRO market. It differentiates itself from large, standardized CROs (like IQVIA, LabCorp, Charles River) by offering highly customized, hands-on service and deep scientific collaboration. It competes with other boutique and specialty CROs, as well as academic contract research units, on the basis of its specific team expertise and flexible, integrated approach.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →